Tumor Heterogeneity and the Dilemma of Antioxidant Therapies in Cancer

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2022 Nov 4

PMID 36330399

Authors

Heloisa Sobreiro Selistre-de-Araujo

Bianca Cruz Pachane

Wanessa Fernanda Altei

Affiliations

Soon will be listed here.

Citing Articles

Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis.

Lin Y, Ku C, Wuputra K, Wu D, Yokoyama K Cells. 2024; 13(19.

PMID: 39404411 PMC: 11475825. DOI: 10.3390/cells13191648.

References

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Chang I, Lin V, Hung C, Wang H, Lin Y, Wu W . GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. World J Urol. 2015; 33(11):1777-89. DOI: 10.1007/s00345-015-1522-7. View

Liu T, Kan X, Ma C, Chen L, Cheng T, Zou Z . GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma. Tumour Biol. 2017; 39(6):1010428317700410. DOI: 10.1177/1010428317700410. View

Ren Z, Liang H, Galbo Jr P, Dharmaratne M, Kulkarni A, Fard A . Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer. Proc Natl Acad Sci U S A. 2022; 119(8). PMC: 8872779. DOI: 10.1073/pnas.2107266119. View

Emmink B, Laoukili J, Kipp A, Koster J, Govaert K, Fatrai S . GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer. Cancer Res. 2014; 74(22):6717-30. DOI: 10.1158/0008-5472.CAN-14-1645. View

Suzuki S, Pitchakarn P, Ogawa K, Naiki-Ito A, Chewonarin T, Punfa W . Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis. Toxicology. 2013; 311(3):115-23. DOI: 10.1016/j.tox.2013.07.005. View

Liu D, Sun L, Tong J, Chen X, Li H, Zhang Q . Prognostic significance of glutathione peroxidase 2 in gastric carcinoma. Tumour Biol. 2017; 39(6):1010428317701443. DOI: 10.1177/1010428317701443. View

Bensinger S, Christofk H . New aspects of the Warburg effect in cancer cell biology. Semin Cell Dev Biol. 2012; 23(4):352-61. DOI: 10.1016/j.semcdb.2012.02.003. View

Baliu-Pique M, Pandiella A, Ocana A . Breast Cancer Heterogeneity and Response to Novel Therapeutics. Cancers (Basel). 2020; 12(11). PMC: 7694303. DOI: 10.3390/cancers12113271. View

10.

Saha A, Harowicz M, Cain E, Hall A, Hwang E, Marks J . Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival. Breast Cancer Res Treat. 2018; 172(1):123-132. PMC: 6588400. DOI: 10.1007/s10549-018-4879-7. View

11.

Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L . Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017; 16(1):76. PMC: 5387196. DOI: 10.1186/s12943-017-0646-3. View

12.

Gawin M, Kurczyk A, Niemiec J, Stanek-Widera A, Grela-Wojewoda A, Adamczyk A . Intra-Tumor Heterogeneity Revealed by Mass Spectrometry Imaging Is Associated with the Prognosis of Breast Cancer. Cancers (Basel). 2021; 13(17). PMC: 8431441. DOI: 10.3390/cancers13174349. View

13.

Ray P, Huang B, Tsuji Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24(5):981-90. PMC: 3454471. DOI: 10.1016/j.cellsig.2012.01.008. View

14.

Walshe J, Serewko-Auret M, Teakle N, Cameron S, Minto K, Smith L . Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 2007; 67(10):4751-8. DOI: 10.1158/0008-5472.CAN-06-4192. View

15.

Lei Z, Tian D, Zhang C, Zhao S, Su M . Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma. BMC Cancer. 2016; 16:410. PMC: 4936229. DOI: 10.1186/s12885-016-2462-3. View

16.

Fumagalli C, Barberis M . Breast Cancer Heterogeneity. Diagnostics (Basel). 2021; 11(9). PMC: 8468623. DOI: 10.3390/diagnostics11091555. View

17.

Minato A, Noguchi H, Ohnishi R, Tomisaki I, Nakayama T, Fujimoto N . Reduced Expression Level of GPX2 in T1 Bladder Cancer and its Role in Early-phase Invasion of Bladder Cancer. In Vivo. 2021; 35(2):753-759. PMC: 8045116. DOI: 10.21873/invivo.12316. View

18.

Du H, Chen B, Jiao N, Liu Y, Sun S, Zhang Y . Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. Oxid Med Cell Longev. 2020; 2020:7370157. PMC: 7079220. DOI: 10.1155/2020/7370157. View

19.

Luond F, Tiede S, Christofori G . Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer. 2021; 125(2):164-175. PMC: 8292450. DOI: 10.1038/s41416-021-01328-7. View

20.

Esparza-Lopez J, Escobar-Arriaga E, Soto-Germes S, Ibarra-Sanchez M . Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities. Rev Invest Clin. 2017; 69(2):66-76. DOI: 10.24875/ric.17002177. View